Welcome to our dedicated page for Macys SEC filings (Ticker: M), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Macy’s, Inc. filings document the public-company disclosures of a retail operator with the Macy’s, Bloomingdale’s and Bluemercury nameplates. Recent Form 8-K reports cover operating results, financial condition, cash flows, non-GAAP measures such as adjusted EBITDA and adjusted earnings, and updates to financial disclosure metrics tied to the company’s go-forward business and comparable-sales reporting.
The company’s proxy and other current reports also describe shareholder meeting matters, board composition, director elections, executive compensation, compensatory arrangements and governance changes. These filings frame Macy’s capital-market reporting around retail performance, disclosure controls, governance structure and shareholder voting processes.
VARGA PAUL C reported acquisition or exercise transactions in this Form 4 filing.
Macy's, Inc. director Paul C. Varga received a grant of 8,348 restricted stock units, each representing one share of Macy's common stock. The award was granted at no cash cost to him and brings his reported restricted stock unit holdings to 8,348.
The restricted stock units vest on the earlier of one year from the grant date or the date of Macy's next annual meeting of shareholders. After vesting, the shares will be automatically deferred and delivered to Varga six months after his service on the Board of Directors ends.
MARKEE RICHARD L reported acquisition or exercise transactions in this Form 4 filing.
Macy's, Inc. director Richard L. Markee received a grant of 8,348 restricted stock units, each representing one share of Macy’s common stock. These units vest on the earlier of one year from the grant date or the next annual shareholder meeting. The vested shares will be automatically deferred and delivered six months after his service on the Board of Directors ends. Following this grant, he holds 8,348 restricted stock units directly, reflecting a routine, compensation-related equity award rather than an open-market stock purchase or sale.
Macy's, Inc. director Jill Granoff received a grant of 8,348 restricted stock units tied to the company’s common stock. Each unit represents one share of common stock and was awarded without a cash exercise price.
The restricted stock units vest on the earlier of one year from the June 5, 2026 grant date or the date of Macy's next annual meeting of shareholders. Once vested, the shares are automatically deferred and will be delivered six months after Granoff’s service on the Board of Directors ends, aligning this award with long-term board tenure and company performance.
Connelly Deirdre P reported acquisition or exercise transactions in this Form 4 filing.
Macy's, Inc. director Deirdre P. Connelly received a grant of 8,348 restricted stock units as equity compensation. Each unit represents one share of Macy's common stock. The units vest on the earlier of one year from the grant date or the next annual shareholder meeting, and the vested shares will be delivered six months after her board service ends.
CHOPRA NAVEEN K. reported acquisition or exercise transactions in this Form 4 filing.
Macy's, Inc. director Naveen K. Chopra received a grant of restricted stock units as part of his equity compensation. The award covers 8,348 restricted stock units, each representing one share of Macy's common stock.
The restricted stock units vest on the earlier of one year from the grant date or the date of Macy's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to Chopra six months after his service on the Board of Directors ends.
Chavez Robert B. reported acquisition or exercise transactions in this Form 4 filing.
Macy's, Inc. director Robert B. Chavez received a grant of 8,348 restricted stock units (RSUs). Each RSU represents one share of Macy's common stock. This is a compensation-related award, not an open-market purchase or sale.
The RSUs vest on the earlier of one year from the grant date or the date of Macy's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to Chavez six months after his service on the Board of Directors ends. Following this grant, Chavez holds 8,348 RSUs directly.
Chandoha Marie A reported acquisition or exercise transactions in this Form 4 filing.
Macy's, Inc. director Marie A. Chandoha received a grant of 8,348 Restricted Stock Units, each equal to one share of common stock. The RSUs vest on the earlier of one year from the grant date or the company’s next annual shareholders meeting, and the vested shares will be deferred and delivered six months after her board service ends.
Boone Torrence reported acquisition or exercise transactions in this Form 4 filing.
Macy's, Inc. director Boone Torrence reported receiving a grant of restricted stock units as equity compensation. The award covers 8,348 restricted stock units, each representing one share of Macy's common stock.
These units vest on the earlier of one year from the grant date or the company’s next annual meeting of shareholders. The vested shares will then be automatically deferred and delivered to Torrence six months after his service on the Board of Directors ends. After this grant, Torrence holds 8,348 restricted stock units directly.
Arel Emilie reported acquisition or exercise transactions in this Form 4 filing.
Macy's, Inc. director Emilie Arel received a grant of 8,348 restricted stock units, each representing one share of Macy's common stock. This is a compensation-related award, not an open-market stock purchase or sale.
The units vest on the earlier of one year from the grant date or the company’s next annual shareholder meeting. After vesting, the resulting shares are automatically deferred and will be delivered to Arel six months after her service on Macy’s Board of Directors ends.
Macy’s, Inc. reported higher results for the first quarter of 2026. Total revenue rose to $4.892 billion from $4.793 billion, with net sales up 1.8% and comparable sales increasing 3.0%. Net income climbed to $63 million, compared with $38 million a year earlier, and diluted earnings per share improved to $0.23 from $0.13.
Gross margin dollars increased slightly, though the gross margin rate slipped 30 basis points, mainly due to tariffs. Adjusted EBITDA was $290 million versus $304 million last year, reflecting higher operating investments and lower real estate gains. Macy’s highlighted broad-based comp sales growth across Macy’s, Bloomingdale’s and Bluemercury under its “Bold New Chapter” strategy.
Liquidity remained solid, with cash and cash equivalents of $1.294 billion and no borrowings under a $2.1 billion asset-based credit facility. The company generated $292 million of operating cash flow, aided by a $328 million litigation settlement, paid $50 million in dividends, and repurchased 2.6 million shares for about $50 million.